Clinical Trial Update: Levels of Circulating T Cells Expressing VLA-1 Collagen Receptors

View source ↗

Summary

The trial update reports on circulating T cells expressing VLA-1 collagen receptors in patients with ischemic heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease

Snippet

Sponsor: Sheba Medical Center | Conditions: Ischemic Heart Disease | Status: COMPLETED